CA Stock MarketDetailed Quotes
CURE.X Biocure Technology Inc
- 0.015
- 0.0000.00%
15min DelayMarket Closed Aug 7 09:30 ET
1.41MMarket Cap-882P/E (TTM)
0.000High0.000Low0Volume0.000Open0.015Pre Close0.00Turnover0.03552wk High0.00%Turnover Ratio94.00MShares0.00552wk Low-0.017EPS TTM1.32MFloat Cap0.035Historical HighLossP/E (Static)87.74MShs Float0.005Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM0.88P/B1Lot Size--Div YieldTTM
About Biocure Technology Inc Company
Biocure Technology Inc is a South Korean-based Bio-Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It Developing Biosimilars and CAR-T Cell pharmaceuticals. Its products are CAR-T Cell Therapy, Interferon Beta, Ranibizumab, and PEG-Filgrastim.
Company Profile
SymbolCURE.X
Company NameBiocure Technology Inc
Founded2007
MarketCNQ
Fiscal Year Ends12-31
Address1055 West Hastings Street Suite 300
CityVancouver
CountryCAN
Zip CodeV6E 2E9
Phone+1 604 609-7149
Websitehttps://www.biocuretech.com
Company Executives
- Name
- Position
- Salary
- Sang Mok Lee
- Director and Chief Executive Officer
- --
- Konstant Lichtenwald
- Chief Financial Officer and Director
- --
- Bjorn Cochlovius
- President
- --
- Berkan Unal
- Director
- --
- Collin Kim
- Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg